Clinical trial

Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet…

NCT00425074 · Rottapharm Spain, Industry · Completed

Key facts

NCT number NCT00425074
Title Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
Official title Pharmacodynamic- Pharmacokinetic Trial, Comparative Double Blind, of the Chronic Administration of 150 mg of Slow Release ASA Versus 150 mg of Normal Release ASA, in the Platelet Functionalism.
Lead sponsor Rottapharm Spain, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Cardiovascular Disease
Intervention type Drug
Interventions slow release acetyl salicylic acid, ASA, SR-ASA
Enrollment 50
Start date Jan 1, 2007
Primary completion Jun 1, 2007
Completion Jul 1, 2007
First posted Jan 22, 2007
Last update posted Jun 8, 2011
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies